ArticleHealth care management science2004
Use of quality adjusted life years and life years gained as benchmarks in economic evaluations: a critical appraisal.
Article in Health care management science, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Statin cost effectiveness in primary prevention: a systematic review of the recent cost-effectiveness literature in the United States.BMC research notes · 2012Pooled it
- Interferon-alpha for maintenance of follicular lymphoma.The Cochrane database of systematic reviews · 2010Pooled it
- Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic review.PharmacoEconomics · 2010Pooled it
- Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies.PharmacoEconomics · 2008Pooled it
- Bias in published cost effectiveness studies: systematic review.BMJ (Clinical research ed.) · 2006Pooled it
- Productivity-adjusted life year loss among the late middle-aged adults in China.Communications medicine · 2025Article
- Costs and cost-effectiveness of integrated horizontal community health worker programmes in low- and middle-income countries (2015-2024): a scoping literature review.BMJ global health · 2025Article
- Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium.Oncotarget · 2017Article
- Article
- The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.Journal of neuro-oncology · 2016Article
- Cost-effectiveness and cost-utility analysis of OTC use of simvastatin 10 mg for the primary prevention of myocardial infarction in Iranian men.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2015Article
- A Cost-Effectiveness Analysis of Surgery for Middle-Aged Men with Severe Obstructive Sleep Apnea Intolerant of CPAP.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2015Article
- Targeted Therapies Compared to Dacarbazine for Treatment of BRAF(V600E) Metastatic Melanoma: A Cost-Effectiveness Analysis.Journal of skin cancer · 2015Article
- A look at statin cost-effectiveness in view of the 2013 ACC/AHA cholesterol management guidelines.Current atherosclerosis reports · 2014Review
- Comparison of two methods of collecting healthcare usage data in chiropractic clinics: patient-report versus documentation in patient files.Chiropractic & manual therapies · 2014Article
- Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications.Diabetes care · 2014Article
- The value of single-pathogen antibacterial agents.Nature reviews. Drug discovery · 2013Review
- Cost-effectiveness of cardiovascular disease spending.Journal of the American College of Cardiology · 2012Article
- The effect of state regulatory stringency on nursing home quality.Health services research · 2012Article
- Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis.Clinical drug investigation · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Researchers have grappled with various ways of placing the results of an economic evaluation in the appropriate context. One of the most common methods is to relate the results of a study to an appropriate benchmark (commonly, dollars 50,000 per QALY in the US or pounds sterling 30,000 per QALY in the UK). This paper examines the foundation for these cut-off points and critiques their use by researchers. Although it is difficult to establish an appropriate benchmark this paper notes that reference points may be too low based on published data. Further, the inconsistent application of benchmarks, and differences in the calculation of a value of a statistical life, will lead to an inefficient allocation of health care resources.
Indexed as
Identifiers
14977093What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.